Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

20092,555 citationsJournal Articlebronze Open Access

Authors

Sam Schulman · McMaster University

Clive Kearon · McMaster University Medical Centre

Ajay K. Kakkar · Queen Mary University of London

Patrick Mismetti

Sebastian Schellong · Krankenhaus Dresden-Friedrichstadt

Henry Eriksson · Sahlgrenska University Hospital

David Baanstra · Boehringer Ingelheim (Netherlands)

Abstract

For the treatment of acute venous thromboembolism, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfarin, and does not require laboratory monitoring. (ClinicalTrials.gov number, NCT00291330.)

Topics & Keywords

Atrial Fibrillation Management and Outcomes Venous Thromboembolism Diagnosis and Management Cardiac Arrhythmias and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 361, Issue 24, pp. 2342-2352

DOI: 10.1056/nejmoa0906598

Field-Weighted Citation Impact: 90.43